Holen Sie sich die Stockscreener-App
4.19
2.95%
0.12
Handel nachbörslich:
4.25
0.06
+1.43%
Schlusskurs vom Vortag:
$4.07
Offen:
$4.03
24-Stunden-Volumen:
63,323
Relative Volume:
0.04
Marktkapitalisierung:
$22.53M
Einnahmen:
$15.66M
Nettoeinkommen (Verlust:
$5.83M
KGV:
-0.1754
EPS:
-23.8939
Netto-Cashflow:
$466.20K
1W Leistung:
+9.69%
1M Leistung:
-8.91%
6M Leistung:
-43.83%
1J Leistung:
+30.12%
1-Tages-Spanne:
$4.0139
$4.29
1-Wochen-Bereich:
$3.81
$4.425
52-Wochen-Spanne:
$3.00
$21.40
Neuphoria Therapeutics Inc Stock (NEUP) Company Profile
Firmenname
Neuphoria Therapeutics Inc
Sektor
Branche
Telefon
781-439-5551
Adresse
100 SUMMIT DR, BURLINGTON
Vergleichen Sie NEUP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NEUP
Neuphoria Therapeutics Inc
|
4.19 | 21.89M | 15.66M | 5.83M | 466.20K | -23.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Neuphoria Therapeutics Inc Stock (NEUP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-09-28 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2023-09-28 | Bestätigt | Maxim Group | Buy |
| 2022-01-10 | Eingeleitet | Berenberg | Buy |
| 2022-01-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-01-10 | Eingeleitet | Evercore ISI | Outperform |
| 2022-01-10 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Neuphoria Therapeutics Inc Aktie (NEUP) Neueste Nachrichten
Why Neuphoria Therapeutics Inc. stock could outperform in 2025Inflation Watch & Stock Timing and Entry Methods - ulpravda.ru
Neuphoria Therapeutics Inc. (NEUP) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
How strong is Neuphoria Therapeutics Inc. stock balance sheetMarket Trend Summary & High Accuracy Swing Entry Alerts - ulpravda.ru
What risks investors should watch in Neuphoria Therapeutics Inc. stock2025 Biggest Moves & Entry Point Strategy Guides - ulpravda.ru
Will Neuphoria Therapeutics Inc. stock see insider buyingMarket Trend Report & Stock Timing and Entry Methods - ulpravda.ru
Does Neuphoria Therapeutics Inc. stock trade at a discount to peers2025 Investor Takeaways & Weekly Watchlist for Consistent Profits - ulpravda.ru
Can Neuphoria Therapeutics Inc. stock double in next 5 years2025 Valuation Update & Weekly High Potential Stock Alerts - ulpravda.ru
Will Neuphoria Therapeutics Inc. stock split again soon2025 Trading Volume Trends & Weekly Hot Stock Watchlists - ulpravda.ru
Growth Recap: How Neuphoria Therapeutics Inc. stock reacts to oil pricesTrade Analysis Summary & Proven Capital Preservation Methods - ulpravda.ru
How Neuphoria Therapeutics Inc. stock reacts to oil prices2025 Momentum Check & AI Forecasted Entry/Exit Points - ulpravda.ru
How Neuphoria Therapeutics Inc. stock benefits from tech adoptionWall Street Watch & Precise Swing Trade Alerts - ulpravda.ru
Setup Watch: How strong is Neuphoria Therapeutics Inc. stock balance sheet2025 Key Lessons & Real-Time Buy Signal Notifications - ulpravda.ru
Is Neuphoria Therapeutics Inc. stock trading near support levels2025 Analyst Calls & Verified Trade Idea Suggestions - ulpravda.ru
Neuphoria Therapeutics Inc. Announces Termination of Spyridon Papapetropoulos as CEO and Appointment as Interim CEO Effective December 31, 2025 - MarketScreener
Neuphoria Therapeutics Announces CEO Transition and Consulting Role - TipRanks
Published on: 2026-01-07 22:57:50 - ulpravda.ru
Is Neuphoria Therapeutics Inc. stock a safe investment in uncertain markets2026 world cup usa national team quarterfinals defensive leaders high defensive line group prediction insights - ulpravda.ru
2026 world cup team news comparison: How buybacks impact Neuphoria Therapeutics Inc. stock value2026 world cup usa national team round of 32 goalkeepers low block defense match prediction expert opinion - ulpravda.ru
Neuphoria Therapeutics to receive $15M milestone payment from Merck - MSN
Aug Intraday: Will Neuphoria Therapeutics Inc stock outperform Dow Jones indexShare Buyback & Low Risk Growth Stock Ideas - moha.gov.vn
Weekly Recap: Why Neuphoria Therapeutics Inc. stock could outperform in 2025Insider Buying & Free Fast Entry Momentum Trade Alerts - ulpravda.ru
Published on: 2025-12-20 15:41:19 - Улправда
Why Neuphoria Therapeutics Inc. stock remains on watchlistsIPO Watch & Weekly Return Optimization Alerts - Улправда
Will Neuphoria Therapeutics Inc. stock remain a Wall Street favoriteJuly 2025 Chart Watch & Daily Entry Point Alerts - DonanımHaber
How Neuphoria Therapeutics Inc. stock reacts to global recession fears2025 Volume Leaders & AI Optimized Trade Strategies - Улправда
Is Neuphoria Therapeutics Inc. stock positioned for digital transformationWeekly Risk Summary & Weekly Stock Breakout Alerts - DonanımHaber
How Neuphoria Therapeutics Inc. stock benefits from global expansionJuly 2025 Drop Watch & Accurate Buy Signal Notifications - DonanımHaber
Neuphoria Therapeutics (NEUP) details 2025 annual meeting and vote outcomes - Stock Titan
Neuphoria Therapeutics (NASDAQ:NEUP) Cut to Strong Sell at Zacks Research - Defense World
Abeona Therapeutics (NASDAQ:ABEO) and Neuphoria Therapeutics (NASDAQ:NEUP) Critical Comparison - Defense World
ISS recommends shareholders vote for Neuphoria’s board nominees By Investing.com - Investing.com Australia
Leading Advisory Firms Recommend Voting FOR Lynx1's Independent Nominees - Yahoo Finance
Institutional Shareholder Services Recommends Shareholders of Neuphoria to Vote for its Director Nominees - marketscreener.com
ISS recommends shareholders vote for Neuphoria’s board nominees - Investing.com
Neuphoria Therapeutics (NEUP) Gains ISS Support for Director Nom - GuruFocus
Finanzdaten der Neuphoria Therapeutics Inc-Aktie (NEUP)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):